These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Patient evaluation of clemastine fumarate and comparison with other antihistamines. Kriz RJ. Wis Med J; 1981 Dec; 80(12):31-3. PubMed ID: 6119852 [No Abstract] [Full Text] [Related]
11. [Clinical experience with the HS-592 in the dysreactive, allergy and exudative processes in E.N.T]. Sánchez García J. Acta Otorinolaryngol Iber Am; 1969 Nov; 20(6):645-57. PubMed ID: 4393808 [No Abstract] [Full Text] [Related]
15. [Clinical study of a new antihistaminic agent, Tavist]. Gyde MC. Vie Med Can Fr; 1972 Feb; 1(2):151-5. PubMed ID: 4404676 [No Abstract] [Full Text] [Related]
16. [Clinical experience with HS-592 (a new antihistaminic) for so-called allergic rhinitis]. Baba S, Oashi M, Seno Y, Maruo T. Penn Dent J (Phila); 1970 Mar; 73(2):319-22. PubMed ID: 4192065 [No Abstract] [Full Text] [Related]
17. Effectiveness of antihistamines in common cold. Sakchainanont B, Ruangkanchanasetr S, Chantarojanasiri T, Tapasart C, Suwanjutha S. J Med Assoc Thai; 1990 Feb; 73(2):96-101. PubMed ID: 1972174 [No Abstract] [Full Text] [Related]
19. A comparison of acrivastine versus clemastine and placebo in the treatment of patients with chronic idiopathic urticaria. Leyh F, Harvey SG, Gibson JR, Manna VK. J Int Med Res; 1989 Feb; 17 Suppl 2():22B-24B. PubMed ID: 2569997 [Abstract] [Full Text] [Related]
20. [Tavegyl in the treatment of allergic diseases and neurovascular disorders of the nose]. Melik A. Schweiz Rundsch Med Prax; 1970 May 05; 59(18):676-8. PubMed ID: 4396440 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]